Curated News
By: NewsRamp Editorial Staff
March 11, 2025
VentiV Scientific Receives NMPA Clearance for Control Medical Thrombectomy Platform in China
Discuss on Reddit
LinkedIn
Substack
Telegram
GithubTLDR
- VentiV Scientific gains market advantage in China with NMPA clearance for Control Medical Thrombectomy platform.
- Control Medical Technology's 7 - 11F Mechanical Thrombectomy System utilizes large-lumen catheters connected to Aspirator for blood clot removal.
- The Control System's innovative design enhances patient outcomes in China by providing clinicians with broader treatment options for various vascular diseases.
- Blood clot removal procedures explained: from accessing femoral artery to applying suction, Control System offers flexible catheters for effective treatment.
Impact - Why it Matters
This news is crucial as it marks a significant achievement for VentiV Scientific in expanding its medical device pipeline into one of the largest global markets. The clearance enables the introduction of an advanced thrombectomy solution, ultimately providing clinicians in China with more treatment options and improving patient outcomes.
Summary
The National Medical Products Administration (NMPA) in China has cleared the Control Medical Technology 7-11F Mechanical Thrombectomy platform, a milestone for VentiV Scientific to enter the Chinese market. Partnering with Shanghai Easy-Flow MedTech, the innovative solution aims to enhance patient outcomes in thrombectomy procedures.
Source Statement
This curated news summary relied on this press release disributed by 24-7 Press Release. Read the source press release here, VentiV Scientific Receives NMPA Clearance for Control Medical Thrombectomy Platform in China
